Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors

被引:68
作者
Haqqani, AS
Sandhu, JK
Birnboim, HC
机构
[1] Ottawa Reg Canc Ctr, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
[3] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada
来源
NEOPLASIA | 2000年 / 2卷 / 06期
基金
英国医学研究理事会;
关键词
disease models; animal; neutrophils; genomic instability; reactive oxygen species;
D O I
10.1038/sj.neo.7900110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neutrophils represent a potential source of genotoxic reactive oxygen and nitrogen species in the tumor microenvironment. Using Mutatect cell lines, which can form subcutaneous tumors in syngeneic C57BL/6 mice, we have previously established that the number of spontaneously infiltrating neutrophils correlates with the number of mutations at the hypoxanthine phosphoribosyltransferase (Hprt) locus. We now describe the properties of four lines that express different levels of the neutrophil chemokine, interleukin-8 (IL-8), from a tetracycline (TET)-responsive promoter. In a series involving 45 animals, IL-8-expressing lines produced tumors with a higher neutrophil content than the control line. Analysis of the 45 tumors revealed that the neutrophil level again strongly correlated with hprt mutant frequency IMF) (P<.0001, r=0.88). Administration of TET was effective in lowering the neutrophil content of low IL-8-expressing tumors, but not high IL-8-expressing tumors. Although the IL-8 transgene was stable in all lines in vitro, high IL-8-expressing lines completely lost the transgene in vivo whereas low IL-8-expressing lines showed no evidence of transgene instability. These results provide further evidence, based on the study of an endogenous gene (hprt) and an IL-8 transgene, that neutrophils may contribute to genetic instability in tumors.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 28 条
[1]  
Bellocq A, 1998, AM J PATHOL, V152, P83
[2]  
BIMBOIM HC, 1999, MUTAT RES, V430, P275
[3]  
BIRNBOIM HC, 1993, SCIENCE, V216, P154
[4]   Transforming growth factor beta 1, interleukin-8 and interleukin-1 in non-small-cell lung tumors [J].
Colasante, A ;
Mascetra, N ;
Brunetti, M ;
Lattanzio, G ;
Diodoro, M ;
Caltagirone, S ;
Musiani, P ;
Aiello, FB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :968-973
[5]   Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis [J].
Desbaillets, I ;
Diserens, AC ;
deTribolet, N ;
Hamou, MF ;
Van Meir, EG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1201-1212
[6]   IMMUNOSELECTION OF GRP94 ENDOPLASMIN FROM A KNRK CELL-SPECIFIC LAMBDA-GT11 LIBRARY USING ANTIBODIES DIRECTED AGAINST A PUTATIVE HEPARANASE AMINO-TERMINAL PEPTIDE [J].
DEVOUGE, MW ;
YAMAZAKI, A ;
BENNETT, SAL ;
CHEN, JH ;
SHWED, PS ;
COUTURE, C ;
BIRNBOIM, HC .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (02) :286-294
[7]   Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma [J].
Eisma, RJ ;
Spiro, JD ;
Kreutzer, DL .
LARYNGOSCOPE, 1999, 109 (05) :687-693
[8]   PRODUCTION AND CHARACTERIZATION OF RECOMBINANT HUMAN NEUTROPHIL CHEMOTACTIC FACTOR [J].
FURUTA, R ;
YAMAGISHI, J ;
KOTANI, H ;
SAKAMOTO, F ;
FUKUI, T ;
MATSUI, Y ;
SOHMURA, Y ;
YAMADA, M ;
YOSHIMURA, T ;
LARSEN, CG ;
OPPENHEIM, JJ ;
MATSUSHIMA, K .
JOURNAL OF BIOCHEMISTRY, 1989, 106 (03) :436-441
[9]  
Galffy G, 1999, CANCER RES, V59, P367
[10]   A myeloperoxidase-specific assay based upon bromide-dependent chemiluminescence of luminol [J].
Haqqani, AS ;
Sandhu, JK ;
Birnboim, HC .
ANALYTICAL BIOCHEMISTRY, 1999, 273 (01) :126-132